Table 3.

Recurrent VTE events during the 60-day study period according to initial anticoagulation strategy

VTE characteristics	Full-dose (n = 75)	Modified-dose (n = 33)	None (n = 13)
Total recurrent VTE events	4 (5)	0	1 (8)
Recurrent VTE event
Distal lower extremity DVT	1 (1)	0	0
Proximal lower extremity DVT	2 (3)	0	0
Upper extremity DVT	0	0	1 (8)
Pulmonary embolism	1 (1)	0	0
Anticoagulant dose at time of recurrent VTE
Full-dose	2 (3)	0	0
Modified-dose	0	0	0
None	2 (3)	0	1 (8)
Anticoagulant at time of recurrent VTE
LMWH	1 (1)	0	0
Unfractionated heparin	1 (1)	0	0
Direct oral anticoagulant	0	0	0